Faculty

For the last 30 years, especially during elections, investors have speculated about the apparent link between stock market behavior and the U.S. presidential election cycle. To the observer, returns seem to be higher during the second half of a president's term than the first. Is it true, or has this phenomenon been merely an intriguing coincidence? A W. P. Carey School of Business finance professor analyzed market behavior going back to 1803 and confirmed that the pattern is real. The reasons why are not so clear.

Your company's most valuable resource may be locked inside the brains of employees. A W. P. Carey School of Business professor has written a paper that describes ways a business can unlock and use this powerful resource. "Measuring Knowledge Management Capabilities" presents a game plan for creating a knowledge management infrastructure that pinpoints knowledge sources and then helps employees solve problems and achieve goals, such as developing new products, raising an existing product's sales or boosting productivity.

Companies know that finding the right people to take care of business is critical for success. But how to attract and hold onto those people? A W. P. Carey School of Business management professor has identified a new use for the branding concept: focusing on human resource management. Companies that develop a brand for their personnel practices have a powerful competitive advantage in the talent marketplace. Some have successfully aligned their employment and product brands, but in many cases the most lasting value results from employment brands that are tied to a firm's core values rather than to its product.

Only a handful of the nation's medical schools now teach molecular science, but soon doctors without this education will be on the road to obsolescence. Scientists are looking deep into the genetic code to find an answer in the molecules to the riddles of disease diagnoses and treatment. Variations within the molecular structure of genes, called haplotypes, may explain why a drug helps one patient but triggers an adverse reaction in another. When fully understood, haplotypes will play a leading role in diagnosis as well as prescription.

When accounting problems at American International Group surfaced last winter, it looked like a small matter next to the corporation–busting scandals of the Enron era. But AIG directors acted as if the company's very survival was at stake, removing Maurice Greenberg as CEO and later forcing him to step down as chairman. The heart of the problem is this: No one can be sure how big the scandal will grow, because it involves business relationships, insurance products and accounting practices so arcane that few people understand them - including a controversial product known as "finite insurance."